ME Therapeutics Holdings Inc.
ME Therapeutics Holdings Inc.
CSE Index:
CSE25Currency:
CAD ME Therapeutics is an early stage Vancouver based biotechnology company involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. Our main focus is on overcoming the suppressive effects of an important class of immune cells called myeloid cells in order to enhance anti-tumour immunity.
ME Therapeutics Holdings Inc. (METX)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Company Info
Address
177 Robson St.
Vancouver, BC V6B 0N3
CanadaPhone
(236) 516-7714Email
Info@metherapeutics.comWebsite
https://www.metherapeutics.comListing date
Thursday, October 12, 2023Transfer Agent
Odyssey Trust CompanySEDAR Information
Filing Type
Any
Timeframe
1 week1 month3 month6 month1 yearAll Time
Company Info
Address
177 Robson St.
Vancouver, BC V6B 0N3
CanadaPhone
(236) 516-7714Email
Info@metherapeutics.comWebsite
https://www.metherapeutics.comListing date
Thursday, October 12, 2023Transfer Agent
Odyssey Trust CompanyCapitalization
Issued & Outstanding:
25189438Reserved for Issuance:
12058890Company Officers
Salim Zulifkar Dhanji, Chief Executive Officer
Quinn Martin, Chief Financial Officer
Jamil Kassam, Corporate Secretary
Bulletins
10/10/2023
2023-1016 - New Listing - ME Therapeutics Holdings Inc. (METX)
le 10 octobre/October 2023
The common shares of ME Therapeutics Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
